Skip to main content

PercayAI CompBio

PercayAI, a recently launched spinout of the Genome Technology Access Center at the McDonnell Genome Institute at Washington University School of Medicine in St. Louis, has introduced its first product, CompBio. Featuring augmented intelligence technology, CompBio is meant to help identify relationships within multi-omic datasets to inform drug discovery. The new company said that the software harnesses neural networks, deep learning, and heuristics so that the machine learns from humans as humans learn from the machine. 

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.